To the full analysis
Esprinet stock: growth
PRT.MIEsprinet reported $4.76B in revenue for fiscal 2025, up 3.6% on the prior year, down 0.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
3.5%
per year from 2006 to 2025, per share 3.8%
Earnings (Annual rate)
−4%
per year from 2006 to 2025, per share −3.8%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | −0.9% | 4.8% | 3.5% |
| Revenue per share | −0.7% | 5.3% | 3.8% |
| Earnings | −8.5% | −4.0% | −4.0% |
| Earnings per share | −8.2% | −3.6% | −3.8% |
| Free cash flow | −8.2% | −4.0% | no data |
| Free cash flow per share | −8.0% | −3.5% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2.47B | $48.93M | −$19.51M |
| 2007 | $2.69B | $34.81M | $136.55M |
| 2008 | $2.63B | $26.82M | $80M |
| 2009 | $2.35B | $35.64M | $80.06M |
| 2010 | $2.44B | $36.43M | −$62.2M |
| 2011 | $2.32B | $8.83M | $53.64M |
| 2012 | $2.14B | $25.86M | $24.68M |
| 2013 | $2.26B | $25.59M | $94.12M |
| 2014 | $2.54B | $29.96M | $550.73K |
| 2015 | $2.99B | $33.6M | $76.7M |
| 2016 | $3.37B | $29.55M | $30.26M |
| 2017 | $3.56B | $29.07M | $24.7M |
| 2018 | $3.96B | $15.55M | $138M |
| 2019 | $4.37B | $25.6M | $171.4M |
| 2020 | $4.98B | $34.8M | $78.26M |
| 2021 | $5.2B | $48.96M | $17.52M |
| 2022 | $5.19B | $52.46M | −$292.36M |
| 2023 | $4.42B | −$13.16M | $171.26M |
| 2024 | $4.59B | $23.85M | −$3.55M |
| 2025 | $4.76B | $22.35M | $50.95M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.